Total Payments
$1,459
2020 Payments
$216.51
Companies
10
Transactions
21
Medicare Patients
2,326
Medicare Billing
$118,429
Payment Breakdown by Category
Food & Beverage$1,459 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,459 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $378.02 | 5 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $210.90 | 3 | $0 (2020) |
| Melinta Therapeutics, Inc. | $197.81 | 2 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, LLC | $156.20 | 2 | $0 (2020) |
| La Jolla Pharmaceutical Company | $121.69 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $113.65 | 3 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $99.39 | 1 | $0 (2017) |
| Philips Electronics North America Corporation | $70.29 | 1 | $0 (2018) |
| Relypsa, Inc. | $63.25 | 1 | $0 (2017) |
| PFIZER INC. | $47.75 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $216.51 | 6 | La Jolla Pharmaceutical Company ($78.56) |
| 2019 | $434.55 | 5 | PORTOLA PHARMACEUTICALS, INC. ($130.81) |
| 2018 | $365.42 | 5 | Melinta Therapeutics, Inc. ($92.63) |
| 2017 | $442.47 | 5 | E.R. Squibb & Sons, L.L.C. ($156.54) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/27/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/24/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/31/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/19/2020 | PORTOLA PHARMACEUTICALS, LLC | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $25.39 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 02/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $52.06 | General |
| Category: Cardiovascular | ||||||
| 01/09/2020 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $78.56 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 08/08/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $47.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $107.68 | General |
| Category: Cardiovascular | ||||||
| 05/09/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | In-kind items and services | $105.18 | General |
| Category: ANTIBIOTICS | ||||||
| 02/13/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $130.81 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 01/10/2019 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $43.13 | General |
| Category: GIAPREZA | ||||||
| 07/12/2018 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | Cash or cash equivalent | $92.63 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/10/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $52.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $61.74 | General |
| Category: Cardiovascular | ||||||
| 03/08/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $87.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/08/2018 | Philips Electronics North America Corporation | IGT_D Peripheral (Device) | Food and Beverage | Cash or cash equivalent | $70.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $123.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $58.49 | General |
| Category: Cardiovascular | ||||||
| 05/10/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $63.25 | General |
| Category: Hyperkalemia | ||||||
| 03/08/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $98.05 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 453 | 494 | $145,157 | $20,854 |
| 2022 | 5 | 601 | 655 | $166,791 | $26,910 |
| 2021 | 6 | 647 | 721 | $192,745 | $34,532 |
| 2020 | 6 | 625 | 669 | $191,208 | $36,133 |
Total Patients
2,326
Total Services
2,539
Medicare Billing
$118,429
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 179 | 192 | $71,879 | $9,429 | 13.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 74 | 83 | $39,094 | $7,463 | 19.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 12 | $12,084 | $1,864 | 15.4% |
| 99282 | Emergency department visit with straightforward medical decision making | Facility | 2023 | 47 | 50 | $12,235 | $1,177 | 9.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 141 | 157 | $9,865 | $920.98 | 9.3% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 177 | 187 | $60,429 | $8,975 | 14.9% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 98 | 101 | $41,257 | $8,744 | 21.2% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 130 | 146 | $32,735 | $4,469 | 13.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 21 | 22 | $20,592 | $3,602 | 17.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 175 | 199 | $11,778 | $1,119 | 9.5% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 198 | 213 | $65,046 | $10,524 | 16.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 52 | 53 | $47,262 | $8,892 | 18.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 87 | 91 | $35,458 | $8,628 | 24.3% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 101 | 113 | $24,288 | $3,541 | 14.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 12 | 12 | $7,302 | $1,534 | 21.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 197 | 239 | $13,389 | $1,412 | 10.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 69 | 71 | $60,576 | $12,607 | 20.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 214 | 232 | $67,936 | $11,083 | 16.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 59 | 60 | $22,000 | $5,560 | 25.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 32 | 32 | $18,612 | $3,908 | 21.0% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2020 | 49 | 50 | $10,172 | $1,559 | 15.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 202 | 224 | $11,912 | $1,418 | 11.9% |
About Dr. Kale Melton, D.O
Dr. Kale Melton, D.O is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1376995324.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kale Melton, D.O has received a total of $1,459 in payments from pharmaceutical and medical device companies, with $216.51 received in 2020. These payments were reported across 21 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,459).
As a Medicare-enrolled provider, Melton has provided services to 2,326 Medicare beneficiaries, totaling 2,539 services with total Medicare billing of $118,429. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Oklahoma City, OK
- Active Since 07/01/2016
- Last Updated 07/01/2016
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1376995324
Products in Payments
- ELIQUIS (Drug) $425.77
- XARELTO (Drug) $210.90
- Orbactiv (Drug) $197.81
- ANDEXXA (Biological) $156.20
- GIAPREZA (Drug) $121.69
- XIFAXAN (Drug) $99.39
- BRILINTA (Drug) $87.77
- IGT_D Peripheral (Device) $70.29
- Veltassa (Drug) $63.25
- LOKELMA (Drug) $25.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Emergency Medicine $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Emergency Medicine $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Emergency Medicine $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Emergency Medicine $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Emergency Medicine $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117
Emergency Medicine $10,117